Digitizing Clinical Trials for Oncology
The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to an improved patient experience by using wearables and patient apps.
Patient Preference
73% of patients are interested in app-based supportive care during radiotherapy.
Physical Activity
Improvement in patient health through correlation of daily steps and severity of symptoms.
Symptom Tracking
ePRO-based symptom monitoring improves QoL as well as OS and reduces emergency hospitalization.
Patient Apps
80% of healthcare providers consider using app-based reports beneficial.
Sleep Quality
Physical activity measured and supported by fitness trackers improved sleep quality in breast cancer survivors.
Medication Adherence
A weekly questionnaire on just six clinical parameters makes it possible to detect a relapse at an early stage, on average six weeks earlier.
Telemedicine
Web-based monitoring and self-scored symptoms with clinician follow-up improved OS and QoL in lung cancer patients.
ePRO/eCOA
Meta-analyses of 30 studies and 5.3k patients show that app interventions improve QoL and alleviate depression.
HANSE Study - Digitalization enables decentralization
Alcedis has conducted a lighthouse lung cancer study where >400,000 potential subjects have been approached, >13,000 patients were screened, and 5,191 patients were recruited in 15 months. Subject data, CT scan evaluation and risk scoring were AI-supported. The recruitment campaign was also supported by Social media, Google Ads, personalized mailings and a strong media presence (newspapers, TV).
Streamlined Patient Journey
Online self-registration with a primary self-assessment for eligibility screening, appointment self-booking of low dose CTs in a mobile CT truck.
Recruitment Success
Recruitment was driven by a high level of public visibility and digital accessibility. Over 60% of participants self-registered online, despite the age of the target group (55-79 years old).
Pioneering Approach
National lung cancer screening program: HANSE study results initiated and supported a national governmental screening program that may already start in 2024.
Trust in our Experience
- We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
- Bringing a high level of academic engagement to deliver the full suite of trial-related services, unlike any traditional contract model.
Suitable Technologies
With our strong technological expertise, we are setting new standards in oncology research with our integrated, patient-centered and data-driven platform.
Discover Technologies
Let's create an impact. Together.
With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of oncology.
Contact